Rina Dvir

3.6k total citations
30 papers, 468 citations indexed

About

Rina Dvir is a scholar working on Genetics, Neurology and Oncology. According to data from OpenAlex, Rina Dvir has authored 30 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 9 papers in Neurology and 6 papers in Oncology. Recurrent topics in Rina Dvir's work include Glioma Diagnosis and Treatment (10 papers), Neuroblastoma Research and Treatments (6 papers) and Acute Lymphoblastic Leukemia research (4 papers). Rina Dvir is often cited by papers focused on Glioma Diagnosis and Treatment (10 papers), Neuroblastoma Research and Treatments (6 papers) and Acute Lymphoblastic Leukemia research (4 papers). Rina Dvir collaborates with scholars based in Israel, United States and Canada. Rina Dvir's co-authors include Liat Ben‐Sira, Shlomi Constantini, Michal Yalon, Amos Toren, Liana Beni‐Adani, Uri Tabori, Ben Shofty, Shlomo Constantini, Michael Weintraub and Anat Kesler and has published in prestigious journals such as Journal of Clinical Oncology, European Journal of Cancer and American Journal of Neuroradiology.

In The Last Decade

Rina Dvir

29 papers receiving 456 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rina Dvir Israel 12 181 134 107 97 66 30 468
Katsunori Asai Japan 10 194 1.1× 145 1.1× 127 1.2× 35 0.4× 66 1.0× 52 355
Yoshihiro Tsukamoto Japan 13 122 0.7× 284 2.1× 85 0.8× 48 0.5× 78 1.2× 65 545
F. Sarrot-Reynauld France 11 91 0.5× 56 0.4× 186 1.7× 87 0.9× 50 0.8× 39 643
Alberto Floris Italy 16 99 0.5× 98 0.7× 172 1.6× 43 0.4× 221 3.3× 51 854
S.P. Hector Spain 11 241 1.3× 70 0.5× 68 0.6× 104 1.1× 81 1.2× 25 455
Jun Kikuchi Japan 13 88 0.5× 40 0.3× 59 0.6× 59 0.6× 65 1.0× 66 594
L.S. Constine United States 8 110 0.6× 116 0.9× 168 1.6× 22 0.2× 99 1.5× 24 449
J. Manuel Sarmiento United States 13 81 0.4× 230 1.7× 70 0.7× 119 1.2× 175 2.7× 35 520
Gaurav Khanna India 14 77 0.4× 76 0.6× 69 0.6× 120 1.2× 107 1.6× 36 566
Kimberly Kicielinski United States 13 276 1.5× 202 1.5× 45 0.4× 138 1.4× 188 2.8× 41 705

Countries citing papers authored by Rina Dvir

Since Specialization
Citations

This map shows the geographic impact of Rina Dvir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rina Dvir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rina Dvir more than expected).

Fields of papers citing papers by Rina Dvir

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rina Dvir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rina Dvir. The network helps show where Rina Dvir may publish in the future.

Co-authorship network of co-authors of Rina Dvir

This figure shows the co-authorship network connecting the top 25 collaborators of Rina Dvir. A scholar is included among the top collaborators of Rina Dvir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rina Dvir. Rina Dvir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Soleman, Jehuda, Rina Dvir, Liat Ben‐Sira, et al.. (2021). MRI-based diagnosis and treatment of pediatric brain tumors: is tissue sample always needed?. Child s Nervous System. 37(5). 1449–1459. 8 indexed citations
3.
Orbach, Daniel, Nicolás André, Ines B. Brecht, et al.. (2020). Mesothelioma in children and adolescents: the European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT) contribution. European Journal of Cancer. 140. 63–70. 12 indexed citations
4.
Roth, Jonathan, et al.. (2020). Pineal region tumors: an entity with crucial anatomical nuances. Child s Nervous System. 37(2). 383–390. 7 indexed citations
5.
Shiran, Shelly I., Liat Ben‐Sira, Ronit Elhasid, et al.. (2018). Multiple Brain Developmental Venous Anomalies as a Marker for Constitutional Mismatch Repair Deficiency Syndrome. American Journal of Neuroradiology. 39(10). 1943–1946. 25 indexed citations
6.
Toledano, Helen, et al.. (2018). INNV-29. EXPERIENCE WITH TTFIELDS (OPTUNE®) IN PEDIATRIC HIGH GRADE GLIOMA PATIENTS IN ISRAEL. Neuro-Oncology. 20(suppl_6). vi144–vi144. 2 indexed citations
7.
Eshel, Rinat, Albert Pinhasov, Menachem Bitan, et al.. (2018). Significant correlation between peripheral blood CD34+ cell count in children prior to aphaeresis and CD34+ cell yield following aphaeresis: A single‐center experience. Pediatric Transplantation. 22(3). e13150–e13150. 2 indexed citations
8.
Bitan, Menachem, Rinat Eshel, Shirley Friedman, et al.. (2016). Combined plerixafor and granulocyte colony‐stimulating factor for harvesting high‐dose hematopoietic stem cells: Possible niche for plerixafor use in pediatric patients. Pediatric Transplantation. 20(4). 565–571. 7 indexed citations
9.
Elhasid, Ronit, Rina Dvir, Menachem Bitan, et al.. (2015). Management of Acute Myeloblastic Leukemia in a Child With Biallelic Mismatch Repair Deficiency. Journal of Pediatric Hematology/Oncology. 37(8). e490–e493. 8 indexed citations
10.
Dvir, Rina, et al.. (2014). Heparanase expression in Langerhans cell histiocytosis. Pediatric Blood & Cancer. 61(10). 1883–1885. 2 indexed citations
11.
Eshel, Rina, Ronit Elhasid, Rina Dvir, et al.. (2013). Screening tool for late‐effect pediatric neuro‐oncological clinics: A treatment‐oriented questionnaire. Pediatric Blood & Cancer. 60(8). 1369–1374. 3 indexed citations
12.
Shofty, Ben, Liat Ben‐Sira, Michal Yalon, et al.. (2011). Visual outcome following chemotherapy for progressive optic pathway gliomas. Pediatric Blood & Cancer. 57(3). 481–485. 52 indexed citations
13.
Toren, Amos, et al.. (2010). Upfront use of gemtuzumab ozogamicin in young children with CD33‐positive AML. Pediatric Blood & Cancer. 55(1). 183–185. 6 indexed citations
14.
Futerman, Boris, Dina Attias, Rina Dvir, et al.. (2009). Burkitt Lymphoma in Children. Journal of Pediatric Hematology/Oncology. 31(6). 428–436. 9 indexed citations
15.
Dvir, Rina, et al.. (2006). Integrated 18F-fluorodeoxyglucose positron emission tomography and computerized tomography in endodermal sinus tumor. International Journal of Gynecological Cancer. 16(4). 1685–1688. 5 indexed citations
16.
Miller, Elka, Ur Metser, Galia Avrahami, et al.. (2006). Role of 18F-FDG PET/CT in Staging and Follow-up of Lymphoma in Pediatric and Young Adult Patients. Journal of Computer Assisted Tomography. 30(4). 689–694. 69 indexed citations
17.
Tabori, Uri, Shlomit Rienstein, Leonor Leider–Trejo, et al.. (2005). Epidermal growth factor receptorgene amplification and expression in disseminated pediatric low-grade gliomas. Journal of Neurosurgery Pediatrics. 103(4). 357–361. 25 indexed citations
18.
Tabori, Uri, Liana Beni‐Adani, Rina Dvir, et al.. (2004). Risk of venous thromboembolism in pediatric patients with brain tumors. Pediatric Blood & Cancer. 43(6). 633–636. 47 indexed citations
19.
Gil, Ziv, et al.. (2001). Ascites following ventriculoperitoneal shunting in children with chiasmatic-hypothalamic glioma. Child s Nervous System. 17(7). 395–398. 39 indexed citations
20.
Dvir, Rina, et al.. (1995). Amniotic fluid and plasma levels of parathyroid hormone-related protein and hormonal modulation of its secretion by amniotic fluid cells. European Journal of Endocrinology. 133(3). 277–282. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026